Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. COCH
COCH logo

COCH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Envoy Medical Inc (COCH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.630
1 Day change
-3.06%
52 Week Range
1.890
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Envoy Medical Inc (COCH) is not a strong buy at this moment for a beginner investor with a long-term focus. Despite insider buying and a positive analyst rating, the technical indicators are bearish, and there are no significant positive catalysts or proprietary trading signals to suggest immediate upside potential. It is better to wait for clearer bullish signals or improved financial data before making an investment decision.

Technical Analysis

The technical indicators for COCH are bearish. The MACD is negatively expanding, the RSI is neutral at 37.696, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock closed below the pivot level of 0.649, with key resistance levels at 0.679 and 0.697 and support levels at 0.62 and 0.602.

Positive Catalysts

  • Insiders are buying, with a significant increase in buying activity (55882.60% over the last month). Analyst H.C. Wainwright initiated coverage with a Buy rating and a $2.50 price target, citing the company's innovative Acclaim Cochlear Implant.

Neutral/Negative Catalysts

  • The stock experienced a 3.12% decline during regular market hours and a 3.55% drop in pre-market trading. Technical indicators are bearish, and there is no recent news or significant hedge fund activity to support a bullish case.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

H.C. Wainwright initiated coverage with a Buy rating and a price target of $2.50, highlighting the company's innovative cochlear implant technology.

Wall Street analysts forecast COCH stock price to rise
Analyst Rating
0
Wall Street analysts forecast COCH stock price to rise
Buy
Hold
Sell
0
Current: 0.654
sliders
Low
0
Averages
0
High
0
0
Current: 0.654
sliders
Low
0
Averages
0
High
0
H.C. Wainwright
Buy
initiated
$2.50
AI Analysis
2026-03-31
Reason
H.C. Wainwright
Price Target
$2.50
AI Analysis
2026-03-31
initiated
Buy
Reason
H.C. Wainwright initiated coverage of Envoy Medical with a Buy rating and $2.50 price target. Envoy is a commercial-stage medical device company focused on the development of novel devices for patients with hearing loss, the analyst tells investors in a research note. The firm says the company's Acclaim Cochlear Implant may be the world's first fully implanted cochlear implant.

People Also Watch